Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TYR | P14679 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PYCR1 | P32322 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19618141 | 0.85 | CHRNA7 (0.48) | DHFRLMNAS1PR1CHRNA7ALDH1A1 | |
| SCHEMBL5431004 | 0.85 | DHFR (0.46) | DHFRLMNAS1PR1ALDH1A1TYR | |
| SCHEMBL20209983 | 0.82 | LMNA (0.39) | DHFRLMNAS1PR1PTGS1TRPA1 | |
| SCHEMBL13367375 | 0.81 | ALDH1A1 (0.52) | DHFRCHRNA7ALDH1A1TSHRALOX15 | |
| SCHEMBL20210157 | 0.78 | S1PR1 (0.45) | DHFRLMNAS1PR1PTGS1TRPA1 | |
| Hydrochloric Acid SCHEMBL28876108 | 0.78 | CHKA (0.46) | LMNAALDH1A1TSHRALOX15 | |
| SCHEMBL13509012 | 0.78 | TSHR (0.42) | ALDH1A1TSHRCYP3A4MAPK1TDP1 | |
| SCHEMBL13333786 | 0.77 | ALDH1A1 (0.45) | DHFRLMNAS1PR1ALDH1A1TYR | |
| P-Cymene SCHEMBL8393048 | 0.75 | ACHE (0.48) | LMNAPTGS1TRPA1CACNA1CCHRNA7 | |
| SCHEMBL18932613 | 0.75 | RXRA (0.44) | DHFRALDH1A1TSHRSMN1; SMN2TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9871211-B2 | Electroactive materials | EI DU PONT DE NEMOURS AND COMPANY (US) | 2018-01-16 | — | — | US | disclosed |
| US-20170338423-A9 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2017-11-23 | — | — | US | disclosed |
| US-20150162536-A1 | ELECTROACTIVE MATERIALS | DU PONT (US) | 2015-06-11 | — | — | US | disclosed |
| US-8992800-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2015-03-31 | — | — | US | disclosed |
| US-8563972-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-10-22 | — | — | US | disclosed |
| US-20130248835-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248839-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-20130248838-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-09-26 | — | — | US | disclosed |
| US-8470960-B2 | Electroactive materials | E I DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-8471251-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2013-06-25 | — | — | US | disclosed |
| US-20120146013-A1 | ELECTROACTIVE MATERIALS | E I DU PONT DE NEMOURS AND COMPANY (US) | 2012-06-14 | — | — | US | disclosed |
| US-20120074396-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-03-29 | — | — | US | disclosed |
| US-8115200-B2 | Electroactive materials | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-02-14 | — | — | US | disclosed |
| US-8067764-B2 | Electroactive materials | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-11-29 | — | — | US | disclosed |
| US-20110101310-A1 | ELECTROACTIVE MATERIALS | E.I. DU PONT DE NEMOURS AND COMPANY | 2011-05-05 | — | — | US | disclosed |
| US-20110095270-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2011-04-28 | — | — | US | disclosed |
| US-20110049477-A1 | ELECTROACTIVE MATERIALS | E I. DU PONT DE NEMOURS AND COMPANY (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110049478-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-03-03 | — | — | US | disclosed |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | E.I.DU PONT DE NEMOURS AND COMPANY | 2011-02-24 | — | — | US | disclosed |
| US-20090159877-A1 | ELECTROACTIVE MATERIALS | E. I. DU PONT DE NEMOURS AND COMPANY | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150162536-A1 | ELECTROACTIVE MATERIALS | KCNN4, SCO2, SYNGR2 | DHFR 3839/4885LMNA 4298/4885S1PR1 1545/4885 |
| US-20110049477-A1 | ELECTROACTIVE MATERIALS | KCNN4, KCNN3, HCN3 | DHFR 3920/4885LMNA 3286/4885S1PR1 830/4885 |
| US-20110049478-A1 | ELECTROACTIVE MATERIALS | KCNN4, RCOR3, HCN4 | DHFR 3484/4885LMNA 3876/4885S1PR1 1575/4885 |
| US-20170338423-A9 | ELECTROACTIVE MATERIALS | KCNN4, RCOR3, HCN4 | DHFR 3484/4885LMNA 3876/4885S1PR1 1575/4885 |
| US-20110101310-A1 | ELECTROACTIVE MATERIALS | KCNN4, SCO2, SYNGR2 | DHFR 3839/4885LMNA 4298/4885S1PR1 1545/4885 |
| US-20120146013-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | DHFR 3625/4885LMNA 4035/4885S1PR1 1208/4885 |
| US-20120074396-A1 | ELECTROACTIVE MATERIALS | KCNN4, RCOR3, HCN4 | DHFR 3484/4885LMNA 3876/4885S1PR1 1575/4885 |
| US-20090159877-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | DHFR 3625/4885LMNA 4035/4885S1PR1 1208/4885 |
| US-20110095270-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | DHFR 3625/4885LMNA 4035/4885S1PR1 1208/4885 |
| US-20110042652-A1 | ELECTROACTIVE MATERIALS | RCOR3, KCNN4, MSRB3 | DHFR 3625/4885LMNA 4035/4885S1PR1 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.